GlassScriptPhysician profile
Mirdula Sharma
NPI 1346695855
$982.94
in general payments reported to CMS, 2019-2025
19 companies · $71.92 in 2025
The $71.92 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.79 · 2020: $80.01 · 2021: $184 · 2022: $208 · 2023: $229 · 2024: $193 · 2025: $71.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $295.96 | 2020-2025 | Rotarix, Pediarix, Bexsero |
| Phadia US INC. | $156.20 | 2021-2025 | Immunocap |
| Merck Sharp & Dohme LLC | $138.74 | 2020-2023 | Verquvo, Dificid, Pifeltro |
| Bayer Healthcare Pharmaceuticals INC. | $59.22 | 2022-2023 | |
| Aurinia Pharma U.S., INC. | $41.15 | 2021-2022 | |
| Novo Nordisk INC | $36.94 | 2023 | Wegovy, Ozempic |
| Ultragenyx Pharmaceutical INC. | $35.52 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $27.99 | 2022 | |
| Sanofi Pasteur INC. | $23.25 | 2025 | |
| Gilead Sciences, INC. | $22.03 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $20.58 | 2024 | Kristalose |
| Amarin Pharma, INC. | $20.00 | 2021 | |
| Kaleo, INC. | $17.59 | 2023 | Auvi-Q |
| Genentech USA, INC. | $16.79 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $15.81 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $14.62 | 2024 | Doc Band |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.61 | 2022 | |
| Pfizer INC. | $13.50 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $13.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mirdula Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.